Results 41 to 50 of about 17,121 (220)

Carcinosarcoma of Liver – A Rare Entity

, 2020
Liver carcinosarcoma is a rare entity, with only 42 cases reported so far. World Health Organization (WHO) has defined carcinosarcoma as a mixture of both carcinomatous and sarcomatous components.
Sruthi Roopa, B.M., Raja , T., Allwyn Yabesh, T., Ramya, A.   +3 more
core   +1 more source

Diagnostic challenges in breast carcinosarcoma: a case report of a rare and aggressive tumor

Frontiers in Medicine
Background and objectivesBreast carcinosarcoma is rare. This article reports a case of diagnosis and treatment to enhance clinicians’ understanding and experience in managing this disease.MethodsA 44-year-old patient with breast carcinosarcoma treated at
Yiwen Li, Caiyun Bai, Yuye Ma, Zhimin Fan, Xiaozhen Wang, Fengjiang Qu   +5 more
doaj   +1 more source

Carcinosarcoma of the breast: A case of breast conservation surgery and breast reconstruction

SAGE Open Medical Case Reports, 2019
Breast carcinosarcoma is an extremely rare, clinically aggressive tumor, and no standard treatment has been established. We report about a 34-year-old woman presenting with a 2.5-cm-sized carcinosarcoma in her right breast.
Hirofumi Kanaizumi, Chihiro Higashi, Yumiko Tanaka, Mika Hamada, Wataru Shinzaki, Yukihiko Hashimoto, Yoshifumi Komoike   +6 more
doaj   +1 more source

Carcinosarcoma of the Larynx-A Rare Site Entity [PDF]

Journal of Clinical and Diagnostic Research, 2016
Carcinosarcoma is a very rare lesion reported in many organs including larynx. The larynx appears to be highly unusual site, only a few cases have been described in the literature. Carcinosarcoma is a mixed tumour.
Byna Syam Sundara Rao, Bhavana Grandhi, Vissa Shanthi, Nandam Mohan Rao, B. Krishna Murthy   +4 more
doaj   +1 more source

β‐Adrenergic Signaling Promotes Anti‐Tumor Immunity in TP53‐mutant Oral Squamous Cell Carcinoma

Advanced Science, EarlyView.
β‐adrenergic stimulation enhances anti‐tumor immunity in TP53‐deficient oral squamous cell carcinoma by inducing tumor‐derived secretion of CXCL10, which attracts and activates cytotoxic CD8+ T cells. The findings demonstrate that β‐adrenergic signaling alters tumor–immune interactions via CXCL10‐mediated paracrine activation, revealing a neuro‐immune ...
Frederico O. Gleber‐Netto, Deborah Silverman, Tongxin Xie, Shamima Akhter, Nicole R. Vaughn, Adewale Adebayo, Kala Chand Debnath, Shorook Naara, Shajedul Islam, Erik Knutsen, Emily Lorin Ashkin, Simone Anfossi, Sara Leahey, Patrick Hwu, Sebastien Talbot, Erica K Sloan, Robert Saddawi‐Konefka, Roberto Rangel, Jeffrey N. Myers, George A. Calin, Moran Amit   +20 more
wiley   +1 more source

Molecular Tumor Boards in Malignant Melanoma: Uncovering Challenges and Opportunities in a Bicenter Retrospective Analysis in Germany

International Journal of Cancer, EarlyView.
Molecular tumor boards (MTB), interdisciplinary teams that use tumor genomic data to guide personalized treatment decisions, have emerged as a promising strategy in melanoma care, although their real‐world clinical impact remains uncertain. This retrospective study evaluated advanced melanoma patients to assess molecularly guided treatment ...
Glenn Geidel, Theresa Lowinus, Patrick Metzger, Rebecca Czurda, Vincent Schipperges, Ulrike Paul, Alessandra Rünger, Julian Kött, Isabel Heidrich, Saskia Lehr, Julia Kühn, Heiko Becker, Cornelius Miething, Martin Werner, Silke Laßmann, Justus Duyster, Tilman Brummer, Ronald Simon, Winfried Alsdorf, Maximilian Christopeit, Carsten Bokemeyer, Kilian Eyerich, Stefan W. Schneider, David Rafei, Melanie Börries, Frank Meiss, Christoffer Gebhardt   +26 more
wiley   +1 more source

Uterine Carcinosarcoma: A rare cause for postmenopausal bleeding: Uterine carcinosarcoma

, 2021
Uterine carcinosarcoma is a rare aggressive tumor also known as Malignant Mixed Mullerian Tumor.  Prognosis is poor with 30-40% having extrauterine involvement at the first presentation and over 10% with distant metastasis.
Shrestha, Eliza, Pandey, Rupam, Mally, Jasma, Ojha, Neebha, Rai, Snigdha   +4 more
core  

Preoperative chemotherapy with docetaxel, cisplatin, and 5-fluorouracil for locally advanced esophageal carcinosarcoma: a case report and review of the literature

Surgical Case Reports, 2018
Background Esophageal carcinosarcoma is a relatively rare malignant neoplasm composed of both epithelial carcinomatous and mesenchymal sarcomatous elements. There is no recommended clinical treatment for esophageal carcinosarcoma because of the rarity of
Tomoko Yoshimoto, Shinichiro Kobayashi, Kengo Kanetaka, Kazuma Kobayashi, Yasuhiro Nagata, Michi Morita, Yuriko Isagawa, Naoe Kinoshita, Mitsuhisa Takatsuki, Susumu Eguchi   +9 more
doaj   +1 more source

Ovarian Cancer: Epidemiology, Disease Mechanisms, New Diagnosis and Treatment Strategies, and Research Directions

iNew Medicine, EarlyView.
ABSTRACT Ovarian cancer (OC) continues to be the deadliest gynecological malignancy and a significant cause of cancer‐related mortality among women worldwide. Standard treatment strategies typically entail platinum‐based chemotherapy in conjunction with cytoreductive surgery.
Zunera Khalid, Weirong Fan, Farah Nazir, Yixiang Xing, Tengchuan Jin   +4 more
wiley   +1 more source

Prostatic Carcinosarcoma: A Case Report

, 2017
WOS: 000408706500008Prostatic carcinosarcoma is a rare malignancy composed of sarcomatous and carcinomatous elements. Predominantly, they are very aggressive tumors with a poor prognosis.
Havva Erdem, Çam, Kamil, Kayıkçı, Muhammet Ali, Şenoğlu, Yusuf, Muhammet Ali Kayıkçı, Ali Tekin, Kamil Çam, Erdem, Havva, Tekin, Ali, Yusuf Şenoğlu   +9 more
core   +2 more sources